샘플 요청 목록

 카트 문의
시장보고서
상품코드
2132493

역류 방지 밸브 시장 규모, 점유율, 동향 분석 보고서 : 용도별, 재질별, 사용 방법별, 최종 용도별, 지역별 및 부문별 예측(2026-2033년)

Anti-Reflux Valve Market Size, Share & Trends Analysis Report By Application (Urinary Drainage, Enteral Feeding), By Material (Silicone, PVC / Vinyl), By Usage (Single Use, Reusable), By End Use, By Region, And Segment Forecasts, 2026 - 2033
발행일: | 리서치사: 구분자 Grand View Research | 페이지 정보: 영문 210 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




가격
Unprintable PDF & Excel (Single User License) help
보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.
US $ 5,950 금액 안내 화살표 ￦ 8,065,000
Printable PDF & Excel (5-User License) help
보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.
US $ 6,950 금액 안내 화살표 ￦ 9,420,000
Printable PDF & Excel (Enterprise License) help
PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.
US $ 8,950 금액 안내 화살표 ￦ 12,131,000
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

역류 방지 밸브 시장 요약

세계의 역류 방지 밸브 시장 규모는 2025년에 12억 달러로 평가되며, 2026년 13억 달러에서 2033년까지 24억 달러로 확대될 것으로 예상되며, 2026년부터 2033년까지 CAGR은 9.2%에 달할 것으로 예측됩니다.

북미가 시장을 주도하고 있으며, 2025년에는 매출 점유율의 37.4%를 차지했습니다. 시장 성장은 경장영양 시스템의 도입 확대, 장기적인 영양 지원이 필요한 만성 질환 유병률 증가, 고령 인구 증가 및 재택의료 서비스의 확대에 의해 견인되고 있습니다.

또한, 장기적인 영양 지원이 필요한 만성 질환의 유병률 증가는 역류 방지 밸브 산업에 중요한 촉진요인이 되고 있습니다. 뇌졸중, 암, 신경 질환, 만성 신장질환, 소화기 질환 등의 병세는 종종 연하 기능이나 소화기 기능을 손상시켜, 장기적인 장내 영양 공급 및 수분 관리의 필요성을 높이고 있습니다. 역류 방지 밸브는 장내 영양 공급 중 역류나 오염을 방지하는 데 매우 중요한 역할을 하여, 이를 통해 환자의 안전을 향상시킵니다. 예를 들어, 세계보건기구(WHO)에 따르면 2025년 9월 시점에서 비전염성 질환(NCD)은 전 세계적으로 최소 4,300만 명의 사망 원인이 되었으며, 팬데믹을 제외한 전체 사망자의 75%를 차지하고 있습니다. 그중 심혈관질환으로 인한 사망자 수는 약 1,900만 명, 암으로 인한 사망자 수는 1,000만 명, 만성 호흡기질환으로 인한 사망자 수는 400만 명, 당뇨병으로 인한 사망자 수는 200만 명 이상이었습니다. 이러한 만성 질환의 부담이 커짐에 따라 장기적인 영양 지원이 필요한 환자 수가 증가하고 있으며, 역류 방지 밸브 기술에 대한 지속적인 수요가 발생하고 있습니다.

병원 인프라 확충은 시장 성장을 뒷받침하는 중요한 요인으로 작용하고 있습니다. 이는 병원이 장내 영양 공급 시스템, 배뇨 시스템, 수액 요법용 기기 및 카테터를 활용한 의료 용도의 주요 최종사용자이기 때문입니다. 환자 입원 건수의 증가, 장기 치료 솔루션에 대한 수요 증가, 그리고 감염 예방에 대한 중요성 부각으로 인해 의료 서비스 제공자들은 신뢰할 수 있는 역류 방지 장치가 장착된 의료기기의 도입을 추진하고 있습니다. 역류 방지 밸브는 요도 카테터, 중심정맥 접근 기기, 배액 시스템 등 카테터 관련 시스템에 통합되어 액체의 역류를 방지하고, 오염 위험을 줄이며, 환자의 안전성을 향상시키는 역할을 합니다. 아래 표에 나와 있듯이, 광범위한 병원 및 전문 의료 시설 네트워크가 존재함으로써 급성기 의료, 중환자 치료, 장기 의료 각 현장에서 역류 방지 밸브 기술에 대한 견고한 수요 기반이 형성되어 있습니다.

자주 묻는 질문

  • 역류 방지 밸브 시장 규모는 어떻게 예상되나요?
  • 북미의 역류 방지 밸브 시장 점유율은 어떻게 되나요?
  • 역류 방지 밸브 시장 성장은 어떤 요인에 의해 이루어지나요?
  • 역류 방지 밸브의 중요성은 무엇인가요?
  • 병원 인프라 확충이 역류 방지 밸브 시장에 미치는 영향은 무엇인가요?

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 역류 방지 밸브 시장 : 변수, 동향, 범위

제4장 역류 방지 밸브 시장 : 용도별 추정·동향 분석

제5장 역류 방지 밸브 시장 : 소재별 추정·동향 분석

제6장 역류 방지 밸브 시장 : 사용법별 추정·동향 분석

제7장 역류 방지 밸브 시장 : 최종 용도별 추정·동향 분석

제8장 역류 방지 밸브 시장 : 지역별 추정·동향 분석

제9장 경쟁 구도

KSM 26.09.28

Anti-Reflux Valve Market Summary

The global anti-reflux valve market size was valued at USD 1.2 billion in 2025 and is projected to grow from USD 1.3 billion in 2026 to USD 2.4 billion by 2033, at a CAGR of 9.2% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 37.4% in 2025. The market growth is driven by the rising adoption of enteral feeding systems, increasing prevalence of chronic diseases requiring long-term nutritional support, growing geriatric population, and the expansion of home healthcare services.

In addition, the increasing prevalence of chronic diseases requiring long-term nutritional support is a significant driver of the anti-reflux valve industry. Conditions such as stroke, cancer, neurological disorders, chronic kidney disease, and gastrointestinal diseases often impair swallowing or gastrointestinal function, increasing the need for long-term enteral feeding and fluid management. Anti-reflux valves play a critical role in preventing backflow and contamination during enteral nutrition, thereby improving patient safety. For instance, in September 2025, according to the World Health Organization (WHO), noncommunicable diseases (NCDs) caused at least 43 million deaths globally, accounting for 75% of all non-pandemic-related deaths. Cardiovascular diseases accounted for approximately 19 million deaths, cancers for 10 million, chronic respiratory diseases for 4 million, and diabetes for over 2 million deaths. The growing burden of these chronic conditions is increasing the number of patients requiring long-term nutritional support, creating sustained demand for anti-reflux valve technologies.

The expanding hospital infrastructure is a key factor supporting the market growth, as hospitals represent major end users for enteral feeding systems, urinary drainage systems, infusion therapy devices, and catheter-based medical applications. Increasing patient admissions, rising demand for long-term care solutions, and a growing emphasis on infection prevention are driving healthcare providers to adopt medical devices equipped with reliable backflow-prevention mechanisms. Anti-reflux valves are integrated into catheter-associated systems, including urinary catheters, central venous access devices, and drainage systems, to help prevent fluid reflux, reduce contamination risks, and improve patient safety. The availability of a large network of hospitals and specialized care facilities creates a strong demand base for anti-reflux valve technologies across acute care, critical care, and long-term healthcare settings, as highlighted in the table below.

Global Anti-Reflux Valve Market Report Segmentation

This report forecasts revenue growth at global, regional & country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global anti-reflux valve market report based on application, material, usage, end use, and region:

  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Urinary Drainage
    • Leg Bags
    • Bedside Urine Collection Bags
    • Other Urinary Drainage Systems
  • Enteral Feeding
    • Enteral Feeding Bags
    • Feeding Pumps & Feeding Sets
    • Gastrostomy Feeding Systems
    • Other Enteral Feeding Systems
  • Vascular Access & Infusion
    • PIVC
    • PICC
    • Midline
    • CVC
    • Other Vascular Access & Infusion
  • Gastrointestinal Drainage & Decompression
    • Gastric Drainage Systems
    • Intestinal Decompression Systems
    • Nasogastric/Enteric Drainage Systems
  • Surgical & Wound Drainage
    • Closed-Suction Wound Drainage
    • Open/Passive Surgical Drainage
  • Respiratory & Thoracic Fluid Management
    • Airway/Tracheobronchial Secretion Drainage
    • Pleural/Chest Tube Drainage
    • Other Respiratory Fluid-Management Systems
  • Other Medical Applications
  • Material Outlook (Revenue, USD Million, 2021 - 2033)
  • PVC / Vinyl
  • Latex / Natural Rubber
  • Silicone
  • Other Medical-Grade Materials
  • Usage Outlook (Revenue, USD Million, 2021 - 2033)
  • Single Use
  • Reusable
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Long-Term Care Facilities
  • Home Healthcare
  • Ambulatory & Outpatient Care
  • Other Healthcare Settings
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Thailand
    • Australia
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Estimates and forecast timeline
  • 1.2. Market Definitions
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
  • 1.5. Details of primary research
    • 1.5.1. Data for primary interviews in North America
    • 1.5.2. Data for primary interviews in Europe
    • 1.5.3. Data for primary interviews in Asia Pacific
    • 1.5.4. Data for primary interviews in Latin America
    • 1.5.5. Data for Primary interviews in MEA
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
      • 1.7.1.1. Approach 1: Commodity flow approach
    • 1.7.2. Volume price analysis (Model 2)
      • 1.7.2.1. Approach 2: Volume price analysis
  • 1.8. Research Scope and Assumptions
    • 1.8.1. List of Secondary Sources
    • 1.8.2. List of Primary Sources
    • 1.8.3. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Anti-Reflux Valve Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Drivers Analysis
      • 3.2.1.1. Rising geriatric population increasing demand for enteral feeding and drainage devices
      • 3.2.1.2. Rising focus on infection prevention and patient safety in medical devices
      • 3.2.1.3. Increasing prevalence of chronic diseases requiring long-term tube-based care
      • 3.2.1.4. Shift toward home-based healthcare and long-term care models
    • 3.2.2. Market Restraints Analysis
      • 3.2.2.1. Risk of anti-reflux valve malfunction, leakage, blockage, and device-related complications
      • 3.2.2.2. Cost pressure and limited reimbursement for specialized medical accessories
    • 3.2.3. Market Opportunity Analysis
      • 3.2.3.1. Expansion of home enteral nutrition and remote patient care solutions
      • 3.2.3.2. Development of smart valves with pressure monitoring and safety features
      • 3.2.3.3. Growth potential in emerging markets due to healthcare infrastructure expansion
      • 3.2.3.4. Rising adoption of pediatric and neonatal feeding solutions
    • 3.2.4. Market Challenge Analysis
      • 3.2.4.1. Maintaining consistent valve performance across multiple clinical applications
      • 3.2.4.2. Competition from integrated devices with built-in reflux prevention features
  • 3.3. Anti-Reflux Valve Market Analysis Tools
    • 3.3.1. Porter's Analysis
      • 3.3.1.1. Bargaining power of the suppliers
      • 3.3.1.2. Bargaining power of the buyers
      • 3.3.1.3. Threats of substitution
      • 3.3.1.4. Threats from new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic and Social landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Environmental landscape
      • 3.3.2.5. Legal landscape

Chapter 4. Anti-Reflux Valve Market: Application Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Anti-Reflux Valve Market: Application Movement Analysis, 2025 & 2033 (USD Million)
  • 4.3. Global Anti-Reflux Valve Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 4.4. Urinary Drainage
    • 4.4.1. Urinary drainage market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.2. Leg Bags
      • 4.4.2.1. Leg Bags market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.3. Bedside Urine Collection Bags
      • 4.4.3.1. Bedside urine collection bags market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.4. Other Urinary Drainage Systems
      • 4.4.4.1. Other urinary drainage systems market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.5. Enteral Feeding
    • 4.5.1. Enteral feeding market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.5.2. Enteral Feeding Bags
      • 4.5.2.1. Enteral feeding bags market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.5.3. Feeding Pumps & Feeding Sets
      • 4.5.3.1. Feeding pumps & feeding sets market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.5.4. Gastrostomy Feeding Systems
      • 4.5.4.1. Gastrostomy feeding systems market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.5.5. Other Enteral Feeding Systems
      • 4.5.5.1. Other enteral feeding systems market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.6. Vascular Access & Infusion
    • 4.6.1. Vascular access & infusion market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.6.2. PIVC
      • 4.6.2.1. PIVC market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.6.3. PICC
      • 4.6.3.1. PICC market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.6.4. Midline
      • 4.6.4.1. Midline market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.6.5. CVC
      • 4.6.5.1. CVC market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.6.6. Other Vascular Access & Infusion
      • 4.6.6.1. Other vascular access & infusion market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.7. Gastrointestinal Drainage & Decompression
    • 4.7.1. Gastrointestinal drainage & decompression market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.7.2. Gastric Drainage Systems
      • 4.7.2.1. Gastric drainage systems market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.7.3. Intestinal Decompression Systems
      • 4.7.3.1. Intestinal decompression systems market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.7.4. Nasogastric/Enteric Drainage Systems
      • 4.7.4.1. Nasogastric/enteric drainage systems market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.8. Surgical & Wound Drainage
    • 4.8.1. Surgical & wound drainage market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.8.2. Closed-Suction Wound Drainage
      • 4.8.2.1. Closed-suction wound drainage market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.8.3. Open/Passive Surgical Drainage
      • 4.8.3.1. Open/Passive Surgical Drainage market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.9. Respiratory & Thoracic Fluid Management
    • 4.9.1. Respiratory & thoracic fluid management market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.9.2. Airway/Tracheobronchial Secretion Drainage
      • 4.9.2.1. Airway/tracheobronchial secretion drainage market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.9.3. Pleural/Chest Tube Drainage
      • 4.9.3.1. Pleural/chest tube drainage market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.9.4. Other Respiratory Fluid-Management Systems
      • 4.9.4.1. Other respiratory fluid-management systems market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.10. Other Medical Applications
    • 4.10.1. Other medical applications market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. Anti-Reflux Valve Market: Material Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Anti-Reflux Valve Market: Material Movement Analysis, 2025 & 2033 (USD Million)
  • 5.3. Global Anti-Reflux Valve Market Size & Trend Analysis, by Material, 2021 to 2033 (USD Million)
  • 5.4. PVC / Vinyl
    • 5.4.1. PVC / vinyl market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.5. Latex / Natural Rubber
    • 5.5.1. Latex / natural rubber market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.6. Silicone
    • 5.6.1. Silicone market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.7. Other Medical-Grade Materials
    • 5.7.1. Other medical-grade materials market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. Anti-Reflux Valve Market: Usage Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Anti-Reflux Valve Market: Usage Movement Analysis, 2025 & 2033 (USD Million)
  • 6.3. Global Anti-Reflux Valve Market Size & Trend Analysis, by Usage 2021 to 2033 (USD Million)
  • 6.4. Single Use
    • 6.4.1. Single use market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.5. Reusable
    • 6.5.1. Reusable market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7. Anti-Reflux Valve Market: End Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Global Anti-Reflux Valve Market: End Use Movement Analysis, 2025 & 2033 (USD Million)
  • 7.3. Global Anti-Reflux Valve Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 7.4. Hospitals
    • 7.4.1. Hospitals market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5. Long-Term Care Facilities
    • 7.5.1. Long-term care facilities market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.6. Home Healthcare
    • 7.6.1. Home healthcare market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.7. Ambulatory & Outpatient Care
    • 7.7.1. Ambulatory & outpatient care market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.8. Other Healthcare Settings
    • 7.8.1. Other healthcare settings market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 8. Anti-Reflux Valve Market: Regional Estimates & Trend Analysis by Application, Material, Usage, and End Use

  • 8.1. Regional Dashboard
  • 8.2. Market Size and Trend Analysis, 2021 to 2033
  • 8.3. North America
    • 8.3.1. North America anti-reflux valve market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.3.2. U.S.
      • 8.3.2.1. Key country dynamics
      • 8.3.2.2. Competitive scenario
      • 8.3.2.3. Regulatory framework
      • 8.3.2.4. Reimbursement scenario
      • 8.3.2.5. U.S. anti-reflux valve market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.3.3. Canada
      • 8.3.3.1. Key country dynamics
      • 8.3.3.2. Competitive scenario
      • 8.3.3.3. Regulatory framework
      • 8.3.3.4. Reimbursement scenario
      • 8.3.3.5. Canada anti-reflux valve market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.3.4. Mexico
      • 8.3.4.1. Key country dynamics
      • 8.3.4.2. Competitive scenario
      • 8.3.4.3. Regulatory framework
      • 8.3.4.4. Reimbursement scenario
      • 8.3.4.5. Mexico anti-reflux valve market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.4. Europe
    • 8.4.1. Europe anti-reflux valve market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.2. UK
      • 8.4.2.1. Key country dynamics
      • 8.4.2.2. Competitive scenario
      • 8.4.2.3. Regulatory framework
      • 8.4.2.4. Reimbursement scenario
      • 8.4.2.5. UK anti-reflux valve market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.3. Germany
      • 8.4.3.1. Key country dynamics
      • 8.4.3.2. Competitive scenario
      • 8.4.3.3. Regulatory framework
      • 8.4.3.4. Reimbursement scenario
      • 8.4.3.5. Germany anti-reflux valve market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.4. France
      • 8.4.4.1. Key country dynamics
      • 8.4.4.2. Competitive scenario
      • 8.4.4.3. Regulatory framework
      • 8.4.4.4. Reimbursement scenario
      • 8.4.4.5. France anti-reflux valve market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.5. Italy
      • 8.4.5.1. Key country dynamics
      • 8.4.5.2. Competitive scenario
      • 8.4.5.3. Regulatory framework
      • 8.4.5.4. Reimbursement scenario
      • 8.4.5.5. Italy anti-reflux valve market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.6. Spain
      • 8.4.6.1. Key country dynamics
      • 8.4.6.2. Competitive scenario
      • 8.4.6.3. Regulatory framework
      • 8.4.6.4. Reimbursement scenario
      • 8.4.6.5. Spain anti-reflux valve market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.7. Sweden
      • 8.4.7.1. Key country dynamics
      • 8.4.7.2. Competitive scenario
      • 8.4.7.3. Regulatory framework
      • 8.4.7.4. Reimbursement scenario
      • 8.4.7.5. Sweden anti-reflux valve market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.8. Denmark
      • 8.4.8.1. Key country dynamics
      • 8.4.8.2. Competitive scenario
      • 8.4.8.3. Regulatory framework
      • 8.4.8.4. Reimbursement scenario
      • 8.4.8.5. Denmark anti-reflux valve market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.9. Norway
      • 8.4.9.1. Key country dynamics
      • 8.4.9.2. Competitive scenario
      • 8.4.9.3. Regulatory framework
      • 8.4.9.4. Reimbursement scenario
      • 8.4.9.5. Norway anti-reflux valve market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Asia Pacific anti-reflux valve market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.2. China
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Competitive scenario
      • 8.5.2.3. Regulatory framework
      • 8.5.2.4. Reimbursement scenario
      • 8.5.2.5. China anti-reflux valve market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.3. Japan
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Competitive scenario
      • 8.5.3.3. Regulatory framework
      • 8.5.3.4. Reimbursement scenario
      • 8.5.3.5. Japan anti-reflux valve market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.4. India
      • 8.5.4.1. Key country dynamics
      • 8.5.4.2. Competitive scenario
      • 8.5.4.3. Regulatory framework
      • 8.5.4.4. Reimbursement scenario
      • 8.5.4.5. India anti-reflux valve market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.5. South Korea
      • 8.5.5.1. Key country dynamics
      • 8.5.5.2. Competitive scenario
      • 8.5.5.3. Regulatory framework
      • 8.5.5.4. Reimbursement scenario
      • 8.5.5.5. South Korea anti-reflux valve market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.6. Australia
      • 8.5.6.1. Key country dynamics
      • 8.5.6.2. Competitive scenario
      • 8.5.6.3. Regulatory framework
      • 8.5.6.4. Reimbursement scenario
      • 8.5.6.5. Australia anti-reflux valve market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.7. Thailand
      • 8.5.7.1. Key country dynamics
      • 8.5.7.2. Competitive scenario
      • 8.5.7.3. Regulatory framework
      • 8.5.7.4. Reimbursement scenario
      • 8.5.7.5. Thailand anti-reflux valve market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.6. Latin America
    • 8.6.1. Latin America anti-reflux valve market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.6.2. Brazil
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Competitive scenario
      • 8.6.2.3. Regulatory framework
      • 8.6.2.4. Reimbursement scenario
      • 8.6.2.5. Brazil anti-reflux valve market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.6.3. Argentina
      • 8.6.3.1. Key country dynamics
      • 8.6.3.2. Competitive scenario
      • 8.6.3.3. Regulatory framework
      • 8.6.3.4. Reimbursement scenario
      • 8.6.3.5. Argentina anti-reflux valve market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.7. Middle East and Africa
    • 8.7.1. Middle East and Africa anti-reflux valve market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.7.2. South Africa
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Competitive scenario
      • 8.7.2.3. Regulatory framework
      • 8.7.2.4. Reimbursement scenario
      • 8.7.2.5. South Africa anti-reflux valve market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.7.3. Saudi Arabia
      • 8.7.3.1. Key country dynamics
      • 8.7.3.2. Competitive scenario
      • 8.7.3.3. Regulatory framework
      • 8.7.3.4. Reimbursement scenario
      • 8.7.3.5. Saudi Arabia anti-reflux valve market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.7.4. UAE
      • 8.7.4.1. Key country dynamics
      • 8.7.4.2. Competitive scenario
      • 8.7.4.3. Regulatory framework
      • 8.7.4.4. Reimbursement scenario
      • 8.7.4.5. UAE anti-reflux valve market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.7.5. Kuwait
      • 8.7.5.1. Key country dynamics
      • 8.7.5.2. Competitive scenario
      • 8.7.5.3. Regulatory framework
      • 8.7.5.4. Reimbursement scenario
      • 8.7.5.5. Kuwait anti-reflux valve market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis by Key Market Participants
  • 9.2. Company Categorization
  • 9.3. Company Market Share Analysis, 2025
  • 9.4. Company Heat Map Analysis
  • 9.5. Strategy Mapping
    • 9.5.1. Expansion
    • 9.5.2. Mergers & Acquisition
    • 9.5.3. Partnerships & Collaborations
    • 9.5.4. New Technology Launches
    • 9.5.5. Research And Development
    • 9.5.6. Company Profiles
    • 9.5.7. BD
      • 9.5.7.1. Company overview
      • 9.5.7.2. Financial performance
      • 9.5.7.3. Product Benchmarking
      • 9.5.7.4. Strategic initiatives
    • 9.5.8. B. Braun SE
      • 9.5.8.1. Company overview
      • 9.5.8.2. Financial performance
      • 9.5.8.3. Product Benchmarking
      • 9.5.8.4. Strategic initiatives
    • 9.5.9. Nexus Medical (Avanos Medical, Inc.)
      • 9.5.9.1. Company overview
      • 9.5.9.2. Financial performance
      • 9.5.9.3. Product Benchmarking
      • 9.5.9.4. Strategic initiatives
    • 9.5.10. Urocare Products, Inc.
      • 9.5.10.1. Company overview
      • 9.5.10.2. Financial performance
      • 9.5.10.3. Product Benchmarking
      • 9.5.10.4. Strategic initiatives
    • 9.5.11. Vygon
      • 9.5.11.1. Company overview
      • 9.5.11.2. Financial performance
      • 9.5.11.3. Product Benchmarking
      • 9.5.11.4. Strategic initiatives
    • 9.5.12. ICU Medical
      • 9.5.12.1. Company overview
      • 9.5.12.2. Financial performance
      • 9.5.12.3. Product Benchmarking
      • 9.5.12.4. Strategic initiatives
    • 9.5.13. Medline
      • 9.5.13.1. Company overview
      • 9.5.13.2. Financial performance
      • 9.5.13.3. Product Benchmarking
      • 9.5.13.4. Strategic initiatives
    • 9.5.14. Go Medical Industries Pty Ltd
      • 9.5.14.1. Company overview
      • 9.5.14.2. Financial performance
      • 9.5.14.3. Product Benchmarking
      • 9.5.14.4. Strategic initiatives
    • 9.5.15. Terumo Corporation
      • 9.5.15.1. Company overview
      • 9.5.15.2. Financial performance
      • 9.5.15.3. Product Benchmarking
      • 9.5.15.4. Strategic initiatives
×

원하시는 정보를 찾아 드릴까요?

보안문자 새로고침
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제
문의
원하시는 정보를
찾아 드릴까요?
문의주시면 필요한 정보를
신속하게 찾아드릴게요.
02-2025-2992
email
문의하기